Eginitio Hospital

At Eginitio Hospital in Athens, clinical research in cardiovascular diseases focuses on preventing recurrent ischemic stroke and improving care after transient ischemic attack. These studies are designed to evaluate whether new treatment approaches can better reduce the risk of another clot-related event while maintaining safety.

• Prevention of ischemic stroke after acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack
• Evaluation of a new oral therapy aimed at reducing clot-related stroke risk
• Safety assessment alongside standard antiplatelet treatment

This area reflects an important effort to improve both stroke prevention and long-term treatment safety for patients at elevated vascular risk.

Research in musculoskeletal diseases at this site includes studies in active idiopathic inflammatory myopathy, a group of conditions that affect muscle strength and function. The trials are mainly focused on understanding long-term safety and tolerability of new therapies, with the broader goal of supporting better disease control and quality of life.

• Active idiopathic inflammatory myopathy
• Long-term safety and tolerability of treatment for inflammatory muscle disease
• Ongoing evaluation of therapy effectiveness in adults

This research helps expand options for patients living with chronic inflammatory muscle disorders and supports more informed treatment decisions.

The 1st Department of Neurology at Eginitio Hospital is also involved in studies of nervous system diseases, especially multiple sclerosis. These trials are aimed at assessing long-term safety and tolerability of emerging therapies for relapsing and progressive forms of the disease, with attention to sustaining treatment benefit over time.

• Multiple sclerosis, including relapsing and progressive forms
• Long-term safety and tolerability of neurological treatment
• Research supporting better management of chronic nervous system disease

This work contributes to the wider effort to improve care for people with complex neurological conditions through careful evaluation of new treatment options.